CIK 0001637715 · <br>Emerging growth company
OnKure Therapeutics, Inc.
Sign in to watch- Ticker
- OKUR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472309515
- Phone
- (720) 307-2892
- Business address
- 6707 WINCHESTER CIRCLE, SUITE 400, BOULDER, CO, 80301
- Former names
- Reneo Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,157
- in 2 filings
Net −$1,157. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 35 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-30 | Manke Isaac Director | Grant or award | +6,311 | 9,780 | ||
| 2025-06-30 | Mathers Edward T Director | Grant or award | +4,694 | 7,274 | ||
| 2025-06-23 | Saccomano Nicholas A President and CEO | Sale | −88 | $2.38 | $210 | 3,594 |
| 2025-06-23 | Leverone Jason A. Chief Financial Officer | Sale | −303 | $2.38 | $722 | 12,906 |
| 2025-05-28 | Phillips Andrew John Director | Grant or award · Stock Option (right to buy) | +7,650 | 7,650 | ||
| 2025-05-28 | Manke Isaac Director | Grant or award · Stock Option (right to buy) | +7,650 | 7,650 | ||
| 2025-05-28 | Jansen Valerie Malyvanh Director | Grant or award · Stock Option (right to buy) | +7,650 | 7,650 | ||
| 2025-05-28 | GREY MICHAEL G Director | Grant or award · Stock Option (right to buy) | +7,650 | 7,650 | ||
| 2025-05-28 | Carruthers R Michael Director | Grant or award · Stock Option (right to buy) | +7,650 | 7,650 | ||
| 2025-05-28 | Mathers Edward T Director | Grant or award · Stock Option (right to buy) | +7,650 | 7,650 | ||
| 2025-05-15 | ACORN BIOVENTURES, L.P. 10% owner | Purchase | +270,270 | $1.85 | $500K | 1,709,944 |
| 2025-05-15 | ACORN BIOVENTURES, L.P. 10% owner | Purchase | +1,129,730 | $1.85 | $2.1M | 1,129,730 |
| 2025-05-15 | Cormorant Asset Management, LP Former 10% Owner | Sale | −1,813,439 | $1.85 | $3.4M | 0 |
| 2025-05-12 | Cormorant Asset Management, LP 10% owner | Sale | −24,300 | $1.99 | $48K | 1,813,439 |
| 2025-04-07 | Saccomano Nicholas A President and CEO | Sale | −516 | $2.67 | $1K | 3,682 |
| 2025-04-07 | Leverone Jason A. Chief Financial Officer | Sale | −1,844 | $2.67 | $5K | 13,209 |
| 2025-04-04 | Saccomano Nicholas A President and CEO | Sale | −358 | $3.33 | $1K | 4,198 |
| 2025-04-04 | Leverone Jason A. Chief Financial Officer | Sale | −1,278 | $3.33 | $4K | 15,053 |
| 2025-03-31 | Manke Isaac Director | Grant or award | +3,469 | 3,469 | ||
| 2025-03-31 | Mathers Edward T Director | Grant or award | +2,580 | 2,580 |
Page 4 of 8 · 154 trades